Maiden Holdings, Ltd. 6.625 NT 2046
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MHLA research report →
Price Chart
About the company
Maiden Holdings Ltd. offers personalized reinsurance services and products, specifically excluding high-impact catastrophic events, to insurance companies ranging from small to medium in size. The firm's operations are divided into two main segments: Diversified Reinsurance and AmTrust Reinsurance.
- CEO
- Patrick Joseph Haveron
- IPO
- 2011
- Employees
- 45
- HQ
- Mount Laurel, NJ, US
Get TickerSpark's AI analysis on MHLA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $686.03M
- P/E
- -0.56
- PEG
- 0.00
- P/S
- 0.95
- P/B
- 0.28
- EV/EBITDA
- -4.77
- Div Yield
- 0.00%
- Gross Margin
- 54.01%
- Op Margin
- -147.20%
- Net Margin
- -152.42%
- ROE
- -43.01%
- ROIC
- -99.44%
Latest fiscal year · YoY change
- Revenue
- $34.05M+785.1%
- Gross Profit
- $25.06M+1256.0%
- Op Income
- $49.61M
- Net Income
- $46.73M+3719.3%
- EPS
- $8.15+6369.2%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $15.15
- 52W Low
- $7.67
- 50D MA
- $8.99
- 200D MA
- $10.88
- Beta
- 0.45
- RSI (14)
- 29
- Avg Volume
- 3.55K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Maiden Holdings reported a significantly better first quarter, but premium volume declined and the company is still navigating competitive pricing, AmTrust moderation, and a strategic review.· May 10, 2018
- Net income improved to $13.7 million, or $0.16 per diluted share, and operating earnings were $16.8 million, or $0.20 per share.
- Gross premiums written fell 7.7% to $853 million, with Diversified down 16% to $279 million and AmTrust down 3% to $574 million.
- Loss development was contained: Diversified had $1.2 million of prior-year development and AmTrust had $8.5 million of adverse development.
- Investment income was steady at $42.9 million, while AOCI marks reduced book value by $0.82 per share due to rising rates.
- The board continues to evaluate strategic alternatives with Bank of America Merrill Lynch engaged to help drive the process.
Maiden reported first quarter 2018 net income attributable to common shareholders of $13.7 million, or $0.16 per diluted common share, versus $20.5 million, or $0.23 per share, in the prior-year quarter. Non-GAAP operating earnings were $16.8 million, or $0.20 per diluted share, versus $22.6 million, or $0.26 per share, and annualized non-GAAP operating return on average common equity was 9.3%. Gross premiums written declined 7.7% to $853 million, driven by Diversified Reinsurance at $279 million, down 16%, and AmTrust Reinsurance at $574 million, down 3%. Net premiums written were $849 million versus $901 million, net premiums earned were $685 million versus $710 million, and net investment income was $42.9 million versus $42.2 million. The combined ratio was 101.8% versus 100.9%; Diversified was 99.6% versus 99.9% and AmTrust was 100.9% versus 99.8%. Prior-year loss development was $1.2 million in Diversified and $8.5 million of adverse development in AmTrust. Book value per common share excluding AOCI was $9.10 versus $9.09 at year-end, while AOCI marks reduced book value by $0.82 per share. Management did not provide formal full-year numeric guidance, but said it expects Diversified revenue to grow in subsequent quarters versus the prior-year period, though not significant year-on-year US growth, and it expects continued moderation and possible further revenue reduction over time in AmTrust.
Arturo Raschbaum said first-quarter results improved significantly after several challenging quarters and emphasized that adverse development was limited compared with prior periods. He framed the business around returning Maiden to more stable results and more consistent profitability, while noting the company is actively pursuing a strategic review with Bank of America Merrill Lynch. His tone was constructive but cautious: he highlighted strength in Capital Solutions and Affinity businesses, but also acknowledged continued pressure in the US and a likely moderation in AmTrust.
Karen Schmitt walked through the quarter’s financials, noting lower gross written premiums, steady investment income, and a slightly weaker combined ratio driven mainly by higher initial loss ratios and higher G&A. She cited $473 million of net loss and LAE versus $481 million last year, G&A of $20 million versus $17.4 million, and a 2.9% G&A ratio versus 2.4%. She also highlighted $68 million of mark-to-market losses through AOCI, a $0.82 per-share book value hit, but said this was not due to credit deterioration and that the company has no significant liquidity risk. Cash and cash equivalents were $161 million, total assets were $6.76 billion, and shareholders’ equity was $1.16 billion; the board also authorized a quarterly cash dividend of $0.15 per common share.
Analysts focused on reserve development, pricing, and the strategic review. On reserves, management said Diversified had a very quiet quarter with US reserves flat and only a small amount of adverse development from Bermuda runoff, while the $8.5 million AmTrust adverse development was concentrated in general liability and some commercial auto, with program business still a challenge. On pricing, management said pro rata auto pricing looks relatively positive in certain areas, but excess reinsurance is seeing more competition and rate pressure, with only marginal primary-market increases and no broad improvement in reinsurance pricing. On the strategic review, management said customers have been largely understanding, collaboration continues, and the objective is to enhance value for both shareholders and clients.
The quarter showed improved earnings, contained adverse development, and stable investment income despite a difficult underwriting backdrop. Management pointed to strong growth outside the US, especially in Capital Solutions and Affinity, and said those areas plus auto and accident health remain places where margins appear attainable.
Premium volume is still under pressure, especially in the US Diversified book, where several accounts were not renewed and management is not expecting significant year-on-year US growth. AmTrust remains a headwind, with management expecting continued moderation and possible further revenue declines, while pricing across much of the market is not improving and some lines are seeing more competition and rate pressure.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 0.0%
- Shares Outstanding
- 86.62M
- Float Shares
- 0
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 3 ETFs
Biggest fund positions in MHLA by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 24, 26 | NIGRO STEVEN HAROLD | buy | 2,500 |
| Jun 10, 26 | NIGRO STEVEN HAROLD | other | 5,718 |
| Jun 10, 26 | Cohen Erik | other | 5,718 |
| Jun 10, 26 | Weissmann Jeffrey | other | 5,718 |
| Jun 10, 26 | Hotchkiss Michael | other | 5,718 |
| Jun 10, 26 | Brecher Joseph | other | 5,718 |
| Mar 18, 26 | Haveron Patrick J | other | 48,596 |
| Mar 18, 26 | Haveron Patrick J | other | 97,192 |
| Mar 18, 26 | Haveron Patrick J | other | 12,749 |
| Mar 14, 26 | Haveron Patrick J | other | 6,724 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MHLA coverage
Recent articles, reports, and earnings notes.
No research on MHLA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MHLA report →